Academic collaborations are key to the success of Nanovi. Our technology platform is a spin-out of the Technical University of Denmark (DTU), and the inventor plays a very active and important role in developing the company.
Nanovi currently participates in two academic collaborations:
Nanoguide (Image-Guided Radiation Therapy using Nanoparticles):
Nanoguide aim to develop a new generation of markers to guide radiotherapy. The partners are DTU (including Nanotech, Risø, Chemistry, and Informatics departments), Rigshospitalet (including Nuclear Medicine and Oncology departments), Purdue University (US), GE Healthcare, and Nanovi. Varian participates on the advisory board with two people.
The project started in 2012 and will run until 2016. The collaboration is supported by a grant from the Danish Council for Strategic Research (DSF). Read more about the project here
GECO (Gels for Combination Cancer Therapy):
The GECO project aims to encapsulate chemotherapeutics within the marker. The objective is to ensure a slow drug release inside the tumor that works synergistically with radiotherapy to eradicate the tumor.